Injecting radioactive antibodies into the cavity left behind from the surgical removal of certain brain tumors, called gliomas, can extend a patient’s life span, according to a new study.
“Weeks matter in this disease,” says Darell D. Bigner of the Duke Comprehensive Cancer Center in Durham, N.C., where he developed the radioactive antibody.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.